Neuropathix, Inc.
NPTX · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,558 | -$4,537 | -$3,451 | $931 |
| Dep. & Amort. | $21 | $16 | $6 | $0 |
| Deferred Tax | $183 | -$752 | $975 | $772 |
| Stock-Based Comp. | $1,352 | $1,723 | $276 | $0 |
| Change in WC | $728 | $602 | $219 | -$125 |
| Other Non-Cash | $385 | $2,005 | $82 | -$2,789 |
| Operating Cash Flow | -$890 | -$944 | -$1,894 | -$1,211 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$7 | $0 | -$42 | -$3 |
| Net Acquisitions | $0 | $0 | $41,950,000 | $290 |
| Inv. Purchases | $0 | $0 | -$27 | -$286,580,000 |
| Inv. Sales/Matur. | $0 | $0 | $1,637 | $538 |
| Other Inv. Act. | -$6,522,000 | $0 | -$41,950,000 | $286,580,000 |
| Investing Cash Flow | -$7 | $0 | $1,567 | $825 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $834 | $594,708,000 | $150,000,000 | $203 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $890 | $845 | $141,191,000 | $689 |
| Financing Cash Flow | $890 | $845 | $141 | $689 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$6 | -$100 | -$186 | $303 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $22 | $121 | $307 | $4 |
| End Cash | $16 | $22 | $121 | $307 |
| Free Cash Flow | -$896 | -$944 | -$1,936 | -$1,214 |